Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TT Venture is the corporate venture capital arm of Türk Telekom, focused on investing in and scaling high-growth technology companies. While it is a broad technology investor, the firm has a significant strategic focus on the healthcare and life sciences sectors, particularly through its investments in digital health, medical imaging, and health-tech platforms. TT Venture provides capital, strategic guidance, and access to Türk Telekom's extensive infrastructure to help its portfolio companies expand both locally and internationally. Notable healthcare-related investments include Virasoft, a digital pathology platform, and other health-tech startups aimed at digitizing medical services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TT Venture.